Stem cell therapy trial reverses “irreversible” damage to cornea
A new study conducted by scientists at Massachusetts Eye and Ear investigated a new treatment that removes stem cells from a patient’s uninjured eye, growing their population in the lab for a few weeks, then surgically transplanting them into the injured eye. The phase 1/2 trial recruited 14 patients to undergo the procedure. By the first checkup at three months, the corneas of seven (50%) of the participants had been completely restored. By the 12-month mark, that number had increased to 11 (79%) patients.